Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Guardant Health, Inc. (GH)

Guardant Health, Inc. (GH) is a recognized leader in liquid biopsy, offering high-precision genetic diagnostics for personalized cancer treatment. The quarterly EPS growth assessment demonstrates profit dynamics, where the -24.70 indicator expresses the state of the metric. However, AI-driven DNA analysis automation is limited by the necessity of manual sampling, while the competition for rare bioinformaticians creates staffing pressure on the R&D segment.

Guardant Health (GH) - Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan saka 04.07.2022 nganti 13.11.2026

Rincian metrik lan analitis perusahaan Guardant Corp (GH)

- rega saham lan konsensus proyeksi valuasi:

Kutipan saham Guardant Health|GH - Rata-rata rega prakiraan

- rincian kapitalisasi pasar:

Nilai pasar Guardant360|GH - Rega Tumbas Perusahaan

- data kapitalisasi buku:

Nilai Buku saben Saham Guardant Health|GH - Pambiji Buku Bisnis|Rasio Nilai Pasar marang Nilai Buku guardanthealth.com|GH - Gunggung Aset Perusahaan

- data tingkat utang lan likuiditas finansial:

Total Utang marang Modal Guardant Health, Inc.|GH - Tanggungan utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas Guardant Health, Inc.|GH - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Guardant360|GH - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Guardant Health|Rasio cepet guardanthealth.com

- indikator bathi lan kelipatan valuasi:

GH - Bathi perusahaan|Proyeksi bathi mangsa ngarep Guardant Health, Inc.|GH - Pangali P/E|Rega marang bathi mangsa ngarep Guardant360|GH - Rasio P/E diaturake wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Guardant360|GH - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Guardant Health|GH - Bathi saben saham sajroning taun lumaku|Wutah bathi EPS kuartalan guardanthealth.com|GH - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Guardant Health, Inc.

Analisis wiwitan perusahaan:Guardant Health - GH

The market values Guardant Health, Inc. (GH) through the lens of its ability to monetize unique oncology patents. This metric measures the percentage change in net earnings per share per quarter, reflecting the efficiency of capital management. Analyzing the quarterly EPS trend allows for the identification of risks regarding declining returns or business stagnation. The company's strong pricing power in the liquid biopsy segment should support a positive trend. Stable growth of this indicator confirms the resilience of the business model amid inelastic demand.

Analisis pesaing

CAI (Caris Life Sciences) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Veracyte Inc (VCYT)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Celcuity Corp|GRAIL Bio (GRAL) - Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi EPS kuartalan MYGN|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan castlebiosciences.com|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Burning Rock BNR|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan VolitionRx Ltd. (VNRX)|Biodesix Corp - Wutah bathi EPS kuartalan|Wutah bathi resik saben saham sajroning taun lumaku Precipio Inc (PRPO)|CHEK (check-cap.com) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|mainzbiomed.com (MYNZ) - Wutah bathi EPS kuartalan|OCX (OncoCyte) - Wutah bathi EPS kuartalan